Nektar Therapeutics (NASDAQ:NKTR)

10.77
Delayed Data
As of Apr 24
 -0.29 / -2.62%
Today’s Change
10.32
Today|||52-Week Range
17.53
-30.52%
Year-to-Date

Today’s Trading

Previous close11.06
Today’s open11.04
Day’s range-- - --
Volume729,027
Average volume (3 months)1,463,985
Market cap$1.4B
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book38.90

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.51-1.86%
NXTMNxStage Medical Inc+0.04+0.21%
KERXKeryx Biopharmaceuti...-0.32-2.73%
PRAHPRA Health Sciences ...-0.53-1.87%
Data as of 04/24/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers